Jury Sides With Novartis In Widow's Bone Drug Suit

Law360, New York (May 26, 2011, 1:37 PM EDT) -- A federal jury in New York on Wednesday sided with Novartis Pharmaceuticals Corp. against a widow claiming Zometa caused her husband's jaw disease, in the first federal trial involving a multiple myeloma patient stemming from the multidistrict litigation over the bone cancer drug.

After a seven-day trial and five hours of deliberation, the jury found Karlene Hogan had not produced enough evidence to prove Zometa had caused her late husband's osteonecrosis of the jaw, a condition that causes the jawbone to deteriorate.

Hogan's suit was remanded...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Hogan v. Novartis Pharmaceuticals Corporation


Case Number

1:06-cv-00260

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Brian M. Cogan

Date Filed

January 19, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.